Free Trial

SOPHiA GENETICS Q2 2024 Earnings Report

SOPHiA GENETICS logo
$3.46 +0.11 (+3.28%)
(As of 01:50 PM ET)

SOPHiA GENETICS EPS Results

Actual EPS
-$0.23
Consensus EPS
-$0.28
Beat/Miss
Beat by +$0.05
One Year Ago EPS
-$0.33

SOPHiA GENETICS Revenue Results

Actual Revenue
$15.81 million
Expected Revenue
$17.58 million
Beat/Miss
Missed by -$1.77 million
YoY Revenue Growth
N/A

SOPHiA GENETICS Announcement Details

Quarter
Q2 2024
Time
Before Market Opens
The 2024 TECH RESET (Ad)

Are we on the edge of the biggest ‘TECH RESET’ in decades?

Click here for the step-by-step details

SOPHiA GENETICS Earnings Headlines

Morgan Stanley Sticks to Its Hold Rating for SOPHiA GENETICS (SOPH)
The 2024 TECH RESET
Are we on the edge of the biggest ‘TECH RESET’ in decades?
Q3 2024 Sophia Genetics SA Earnings Call
See More SOPHiA GENETICS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SOPHiA GENETICS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SOPHiA GENETICS and other key companies, straight to your email.

About SOPHiA GENETICS

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

View SOPHiA GENETICS Profile

More Earnings Resources from MarketBeat